$4.86
-0.19-3.76%
Últ. Act.: Oct 28, 7:52 PM
Adial Pharmaceuticals Inc (ADIL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-11.25 | $-1.01 | -1013.9 % |
| Q1 | May 8, 2026 | $-1.48 | $-2.15 | 31.2 % |
| Q4 | Mar 6, 2026 | $-11.48 | $-2.12 | -441.5 % |
| Q3 | Nov 13, 2025 | $-2.00 | $-2.75 | 27.3 % |
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.01 | $-2.15 | $-2.12 | $-2.75 |
| Actual | $-11.25 | $-1.48 | $-11.48 | $-2.00 |
| Surprise | -1013.9% | +31.2% | -441.5% | +27.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-2.34 | $-2.36 |
| Revenue | ||
| Consensus | — | — |